肝细胞癌的分子靶向治疗进展

被引：4

作者：

陈磊

李德卫

机构：

[1] 重庆医科大学附属第一医院肝胆外科

来源：

胃肠病学和肝病学杂志 | 2010年 / 19卷 / 08期

关键词：

肝细胞癌; 分子靶向治疗;

D O I：

暂无

中图分类号：

R735.7 [肝肿瘤];

学科分类号：

100112 [医学生物化学与分子生物学];

摘要：

肝细胞癌是临床常见的恶性肿瘤,传统的手术及化疗难以使患者受益。近年来,分子靶向治疗对一些肿瘤已取得突破性进展,肝癌的分子靶向治疗也在临床试验中取得了令人鼓舞的结果。本文针对肝癌的分子靶向治疗的研究进展做一综述。

引用

页码：694 / 697

页数：4

共 5 条

[1]

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J].

Cheng, Ann-Lii ;

Kang, Yoon-Koo ;

Chen, Zhendong ;

Tsao, Chao-Jung ;

Qin, Shukui ;

Kim, Jun Suk ;

Luo, Rongcheng ;

Feng, Jifeng ;

Ye, Shenglong ;

Yang, Tsai-Sheng ;

Xu, Jianming ;

Sun, Yan ;

Liang, Houjie ;

Liu, Jiwei ;

Wang, Jiejun ;

Tak, Won Young ;

Pan, Hongming ;

Burock, Karin ;

Zou, Jessie ;

Voliotis, Dimitris ;

Guan, Zhongzhen .

LANCET ONCOLOGY, 2009, 10 (01) :25-34

[2]

Effects of the mTOR inhibitor sirolimus in patients with hepatocellular and cholangiocellular cancer [J].

Rizell, Magnus ;

Andersson, Mats ;

Cahlin, Christian ;

Hafstrom, Larsolof ;

Olausson, Michael ;

Lindner, Per .

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2008, 13 (01) :66-70

[3]

Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma [J].

Vejchapipat, P ;

Tangkijvanich, P ;

Theamboonlers, A ;

Chongsrisawat, V ;

Chittmittrapap, S ;

Poovorawan, Y .

JOURNAL OF GASTROENTEROLOGY, 2004, 39 (12) :1182-1188

[4]

Reactivation of the insulin-like growth factor-Ⅱsignaling pathway in human hepatocellular carcinoma.[J].Kai Breuhahn;Peter Schirmacher;.World Journal of Gastroenterology.2008, 11

[5]

Effect of blocking IGF-I receptor on growth of human hepatocellular carcinoma cells [J].

Zhang, You-Cheng ;

Wang, Xiao-Peng ;

Zhang, Ling-Yi ;

Song, Ai-Lin ;

Kou, Zhi-Min ;

Li, Xu-Sheng .

WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (25) :3977-3982

← 1 →